iiinova — where your digital self keeps evolving

James Larkin @jameslarkin13.bsky.social · 19/11/2025

A key strategy of commercial actors is to influence and distort the evidence base relating to the harms of their products This is done through funding misleading industry-friendly science & through the active promotion of misinformation @markpetticrew.bsky.social @aimosinc.bsky.social #AIMOS2025

0103

James Larkin @jameslarkin13.bsky.social · 18/11/2025

"I'm not influenced." "My colleagues are influenced, but I'm not." "I have ties with all the, companies, so I'm not influenced by any.” Lisa Bero describing the ways people rationalise their conflicts of interest, opening the #AIMOS2025 conference @aimosinc.bsky.social

2289

Reposted by James Larkin

Margaret McCartney @mgtmccartney.bsky.social · 26/09/2025

sign up sign up come along to our first event 31st october or add yourself to our mailing list for a streamed section of the day. it's going to be excellent. no sponsorship, independent, and amazing people are coming medicine.st-andrews.ac.uk/centreforevi...

medicine.st-andrews.ac.uk

The Centre for Evidence and Values

[et_pb_section fb_built=1 disabled_on=off|off|off admin_label=Header Image and Nav Box _builder_version=4.27.4 _module_preset=default background_color=#FFFFFF background_image=https://medicine.st-andr...

035

James Larkin @jameslarkin13.bsky.social · 12/09/2025

Less inequality = fewer problems @profkepickett.bsky.social lays our her vision for a good society at #SSM2025 @socsocmed.bsky.social

052

James Larkin @jameslarkin13.bsky.social · 11/09/2025

Research by alcohol industry funded organisations like DrinkAware often distorts health evidence In that context, Alice Thompson presents on alcohol industry funded research on drink spiking #SSM2025 @socsocmed.bsky.social @markpetticrew.bsky.social @maizie333.bsky.social @spidermaani.bsky.social

0100

Reposted by James Larkin

Human Rights Watch @hrw.org · 10/09/2025

There is nowhere safe to go in Gaza. Israeli forces have ordered thousands of Palestinians in Gaza City to evacuate as the military prepares another major assault. States should act to prevent genocide in Gaza and press Israel to reverse course.

58262

James Larkin @jameslarkin13.bsky.social · 10/09/2025

Do unhealthy commodity advertising restrictions affect energy consumption, have unintended effects and are there loopholes? Great presentation by @frankdv.bsky.social discussing his evaluation of the Bristol unhealthy commodity advertising restrictions #SSM2025 @socsocmed.bsky.social

031

James Larkin @jameslarkin13.bsky.social · 10/09/2025

“Advertising is one of most effective ways of promoting harmful commodity use” Excellent presentation by @michaelpdaly.bsky.social on what policy restrictions local authorities place on harmful commodity advertising, & what factors impede or facilitate these policies #SSM2025 @socsocmed.bsky.social

042

James Larkin @jameslarkin13.bsky.social · 15/08/2025

Pharmaceutical payments to general practices rose from £2.5 mill in 2015 to £7.5 mill in 2022. 54 companies made payments, but one company, Chiesi—marketing respiratory inhalers—accounted for >50% of payments since 2017 The payment growth and the dominance of one company raise concerns about bias

034

Reposted by James Larkin

Marita Hennessy @maritahennessy.bsky.social · 27/06/2025

"Patient Partnership Week has been sponsored by Abbott, Amgen, AstraZeneca & Novartis" www.patients-association.org.uk/news/patient... Our commentary on commercial influences on patient & public involvement ➡️ academic.oup.com/heapro/artic... @jameslarkin13.bsky.social @healthpromint.bsky.social

patients-association.org.uk

Patient Partnership Week 2025

We’ve launched Patient Partnership Week 2025! Find out more and book to attend our free webinars.

086

James Larkin @jameslarkin13.bsky.social · 20/06/2025

"Transfers of value can create conflicts of interest, and I understand that some international research has linked them to higher prescribing rates, higher costs and lower prescribing quality." - Kieran O'Donnell TD

100

James Larkin @jameslarkin13.bsky.social · 20/06/2025

"The significant consequences of poorly managed conflicts of interest in healthcare have been highlighted in many countries. Examples include the US opioid epidemic[...] and the pelvic mesh scandal in Britain." - Darren O'Rourke TD

111

James Larkin @jameslarkin13.bsky.social · 20/06/2025

Yesterday the Dáil debated legislation to legally mandate public disclosure of payments from pharmaceutical & medical device company payments to healthcare professionals and healthcare organisations. It was refreshing to hear insightful contributions from government and opposition TDs thread: 1/4

121

James Larkin @jameslarkin13.bsky.social · 20/06/2025

Thanks Rikke, hope you’re doing well.

000

James Larkin @jameslarkin13.bsky.social · 19/06/2025

Great to speak alongside Kath Sansom & Kieran Harkin in the Oireachtas audiovisual room, outlining the need for sunshine legislation: legally mandated public disclosure of payments from pharmaceutical and medical device company payments to healthcare professionals and healthcare organisations.

162

James Larkin @jameslarkin13.bsky.social · 12/06/2025

Congrats Maurice. Well deserved

000

Reposted by James Larkin

Research Ireland @researchireland.ie · 09/06/2025

We are pleased to announce that applications are now open for the New Foundations Scheme. The scheme supports eligible researchers who intend to pursue research, networking or dissemination activities within and across the diversity of disciplines. Go to: researchireland.ie/funding/new-foundations/

034

Reposted by James Larkin

James Larkin @jameslarkin13.bsky.social · 03/06/2025

On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds. We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for. shorturl.at/erwpH

shorturl.at

Should the maker of Ozempic be funding children’s playgrounds in Ireland?

In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals

078

James Larkin @jameslarkin13.bsky.social · 03/06/2025

shorturl.at

Should the maker of Ozempic be funding children’s playgrounds in Ireland?

In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals

078

James Larkin @jameslarkin13.bsky.social · 28/05/2025

Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555 shorturl.at/l7OAh

sciencedirect.com

Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults

To assess impacts of government changes to prescription medicine co-payments on individuals’ out-of-pocket expenditure.Participants were community-dwe…

111

Reposted by James Larkin

Hannah Forde @hannahforde.bsky.social · 27/05/2025

Funded PhD opportunity at the University of Liverpool to explore the mental health and environmental impacts of outdoor advertising, focusing on meat and dairy www.findaphd.com/phds/project...

findaphd.com

The psychology of outdoor advertising at University of Liverpool on FindAPhD.com

PhD Project - The psychology of outdoor advertising at University of Liverpool, listed on FindAPhD.com

035

Reposted by James Larkin

James Packard Love @jamielove.bsky.social · 19/05/2025

$1000 per day for risdiplam from Roche for treatment of SMA.

111

James Larkin @jameslarkin13.bsky.social · 19/05/2025

Strange that that isn't on the poster either

120

James Larkin @jameslarkin13.bsky.social · 19/05/2025

Strange that a pharmaceutical industry funded children's poster about intellectual property doesn't mention intellectual property's role in millions of deaths in the COVID pandemic and HIV/AIDS epidemic It's more focused on how IP helps companies "grow and fund further research" ‪@abpi.bsky.social‬

190

Reposted by James Larkin

Uplift Ireland @uplift.ie · 13/05/2025

Greyhound racing is a cruel industry where thousands of dogs are killed every year. It is an industry that only benefits the gambling companies and bookmakers. We are calling for a ban on cruel, unpopular Greyhound racing once and for all. #Speirgorm

my.uplift.ie

Ban Greyhound Racing now

I am calling on the Government to ban cruel Greyhound racing. Will you do the same?

075

James Larkin @jameslarkin13.bsky.social · 09/05/2025

Grateful to have gotten @researchireland.ie funding to conduct a study with Alcohol Forum Ireland exploring corporate influences on public health alcohol policy. @paulaleonard.bsky.social

151

Reposted by James Larkin

Shaun Lintern @shaunlintern.bsky.social · 20/04/2025

🚨 INVESTIGATION: Private clinics delivering NHS cataract surgery face investigation over claims they have artificially inflated costs for the taxpayer, performed unnecessary operations and incentivised high-street optometrists to refer patients to them: www.thetimes.com/article/245f...

thetimes.com

Private cataract clinics investigated while making millions from NHS

Health service bosses fear price inflation and unnecessary operations are costing the taxpayer. Now a fraud unit is getting involved

1613480

Reposted by James Larkin

Institute of Alcohol Studies @ias.org.uk · 08/04/2025

Spot the difference 🔎 Left: A Guinness ad near an Irish primary school before a complaint. Right: After the complaint - now Guinness 0.0. A dangerous loophole lets alcohol brands dodge ad restrictions by promoting zero-alcohol products. It's time to close it. Found by @jameslarkin13.bsky.social

01918

James Larkin @jameslarkin13.bsky.social · 04/04/2025

Pleased to play a part in this publication on Zero Alcohol in Ireland lnkd.in/eQgXv_pZ 0.0 alcohol is being used as a loophole to facilitate alcohol marketing near schools See images from my town Left: Guinness ad before I complained that it's within 200m of a school, Right: after I complained

24011

James Larkin @jameslarkin13.bsky.social · 03/04/2025

A true team effort with excellent co-authors @andersprior.bsky.social (Aarhus University) @susmith.bsky.social (@tcddublin.bsky.social) Line Due Christensen, Thomas Voss, Claus Høstrup Vestergaard and Amanda Paust

000

James Larkin @jameslarkin13.bsky.social · 03/04/2025

Options for addressing this: 1. Expanding free access to low-income groups, as they are both more likely to have multimorbidity and less likely to afford their medicines. 2. Use mechanisms to optimise prescribing practice and potentially reduce costs

100

James Larkin @jameslarkin13.bsky.social · 03/04/2025

Average annual expenditure was €320 for people with ≥5 chronic conditions, €187 for 2 conditions and €44 for 0 conditions. Higher expenditure amongst those with multimorbidity was compounded by their lower household incomes.

100

James Larkin @jameslarkin13.bsky.social · 03/04/2025

🚨Publication We assessed the impact of multimorbidity on out-of-pocket prescription medicine expenditure for all adults in Denmark Even in Denmark, with large government subsidies, people with multimorbidity are vulnerable to high prescription medicine expenditure shorturl.at/caQDW

sciencedirect.com

The association between multimorbidity and out-of-pocket expenditure for prescription medicines among adults in Denmark: A population-based register study

Multimorbidity, defined as two or more chronic conditions in an individual, is increasing in prevalence and is associated with polypharmacy. Polypharm…

100

James Larkin @jameslarkin13.bsky.social · 31/03/2025

Proud to have supported this letter to @rthonwesstreeting.bsky.social The UK (& Ireland) need a conflict of interest disclosure system detailing the payments that pharmaceutical & medical device companies make to healthcare professionals, healthcare organisations and patient organisations

132

Reposted by James Larkin

Marita Hennessy @maritahennessy.bsky.social · 26/03/2025

Looking through @easoobesity.bsky.social #ECO2025 list of sponsors - having diversity in pharma cos. appears to be #Obesity #COI mgt strategy in recent yrs* Also interesting to see Pronokal (Nestlé) back (can't claim lack of awareness this time www.bmj.com/content/380/...) eco2025.org?p=sponsors

eco2025.org

32nd European Congress on Obesity

121

Reposted by James Larkin

James Larkin @jameslarkin13.bsky.social · 19/03/2025

📢Publication We examined almost every multi-centre RCT with an Irish centre & found big reporting issues 🔎only 27% of RCTs reported number of participants recruited in Ireland Huge €'s are devoted to Irish RCT infrastructure, yet levels of Irish involvement in RCTs aren't clear shorturl.at/9mmGk

sciencedirect.com

Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch study

Multi-center randomized controlled trials (RCTs) provide vital information about healthcare interventions. Reporting on country-level participation is…

165

James Larkin @jameslarkin13.bsky.social · 19/03/2025

Thanks to co-authors: @frankmoriarty.bsky.social, Uchechukwu Alanza, Vikneswaran Raj Nagarajan, Maurice Collins, Sami Termanini, Emmet Farrington, Barbara Clyne and Tom Fahey, @rcsi.bsky.social @rcsipophealth.bsky.social @rcsi-research.bsky.social @rcsialumni.bsky.social

020

James Larkin @jameslarkin13.bsky.social · 19/03/2025

Other key findings 🔎75.3% of the included RCTs reported the number of Irish centers 🔎only 8% of RCTs published after 1996 reported using a reporting guideline.

111

James Larkin @jameslarkin13.bsky.social · 19/03/2025

sciencedirect.com

Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch study

Multi-center randomized controlled trials (RCTs) provide vital information about healthcare interventions. Reporting on country-level participation is…

165